Literature DB >> 2741624

Influence of aspirin and steroids on acute lung injury after i.v. Injection of a sclerosing agent.

G H Sigurdsson1, S Vallgren, J T Christenson.   

Abstract

Recently it was reported that sclerosing agents frequently used for sclerotherapy of bleeding oesophageal varices can cause severe lung injury, resembling that of the adult respiratory distress syndrome (ARDS), if given intravenously to sheep. The aim of the present series was to study if steroids or aspirin given before injection of the sclerosing agent would modify or prevent the lung injury. Twenty-one sheep were randomly given either normal saline (S, 20 ml i.v., n = 8), methyl prednisolone (MP, 40 mg/kg bwt i.v., n = 6) or aspirin (ASP, 10 mg/kg bwt i.v., n = 7) 20 min before ethanolamine oleate 5% 5 ml i.v. was given. After injection of the sclerosing agent the untreated animals (S) developed a high pulmonary artery pressure (PAP) while the respiratory compliance (CT), arterial oxygen tension (PaO2) as well as the platelet (PC) and white cell counts (WBC) decreased significantly. In group MP the pulmonary changes were less severe (CT, PaO2) and the drop in PC as well as WBC was less pronounced, but the PAP increased just as much as in the controls (S). In the aspirin treated group (ASP), however, no pulmonary or circulatory changes were observed. PAP, PaO2, CT, PC and WBC remained virtually unchanged throughout the study. At post mortem the lungs of the control animals appeared moderately congested and the wet/dry weight ratio was significantly increased compared with group ASP. It was concluded that methyl prednisolone slightly attenuates acute lung injury observed after i.v. injection of the sclerosing agent ethanolamine oleate. Aspirin, on the other hand, appears to prevent this injury almost entirely.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741624

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  8 in total

1.  Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.

Authors:  Daryl J Kor; Jason Erlich; Michelle N Gong; Michael Malinchoc; Rickey E Carter; Ognjen Gajic; Daniel S Talmor
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

2.  Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study.

Authors:  Jason M Erlich; Daniel S Talmor; Rodrigo Cartin-Ceba; Ognjen Gajic; Daryl J Kor
Journal:  Chest       Date:  2010-08-05       Impact factor: 9.410

Review 3.  Prevention or Treatment of Ards With Aspirin: A Review of Preclinical Models and Meta-Analysis of Clinical Studies.

Authors:  Bernardo Amisa Panka; Harm-Jan de Grooth; Angélique Maria Elisabeth Spoelstra-de Man; Mark R Looney; Pieter-Roel Tuinman
Journal:  Shock       Date:  2017-01       Impact factor: 3.454

4.  Role of diabetes in the development of acute respiratory distress syndrome.

Authors:  Shun Yu; David C Christiani; B Taylor Thompson; Ednan K Bajwa; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

5.  Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats.

Authors:  C Song; S Suzuki; H Kubo; M Chida; Y Hoshikawa; T Tabata; T Kondo
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

6.  Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis.

Authors:  Huoyan Liang; Xianfei Ding; Hongyi Li; Lifeng Li; Tongwen Sun
Journal:  Front Pharmacol       Date:  2020-05-19       Impact factor: 5.810

7.  Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury.

Authors:  Daryl Jon Kor; Daniel S Talmor; Valerie M Banner-Goodspeed; Rickey E Carter; Richard Hinds; Pauline K Park; Ognjen Gajic; Michelle N Gong
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692

8.  A case of noncardiogenic pulmonary edema by ethanolamine oleate.

Authors:  J Y Lee; S H Moon; S M Lee; H T Kim; S Uh; Y H Kim; C S Park
Journal:  Korean J Intern Med       Date:  1994-07       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.